Oppenheim to Asharq Al-Awsat: Our Problem Isn’t Houthis, It’s Their Destructive Behavior

UK Ambassador to Yemen Richard Oppenheim
UK Ambassador to Yemen Richard Oppenheim
TT

Oppenheim to Asharq Al-Awsat: Our Problem Isn’t Houthis, It’s Their Destructive Behavior

UK Ambassador to Yemen Richard Oppenheim
UK Ambassador to Yemen Richard Oppenheim

The UK ambassador to Yemen, Richard Oppenheim, acknowledged that he has direct communication channels with the Houthis and confirmed that he had dined with the group’s spokesman, Mohammed Abdulsalam, in Muscat three months ago, as did his predecessor Michael Aron.

In an interview with Asharq Al-Awsat, Oppenheim affirmed that the problem with Houthis is in their destructive behavior, not in them being a Yemeni group or participating in government. He reiterated the UK’s condemnation of their recent attacks on oil ports, describing them as “terrorist attacks.”

While expressing concerns about consequences of the internationally recognized government designating Houthis as a “terrorist group,” he expressed his hope that the group would participate in Yemen’s Presidential Leadership Council (PLC).

Oppenheim also stressed the importance of maintaining the calm and supporting the efforts of the UN envoy to reach a lasting peace.

The British diplomat explained his country’s views on many Yemeni files, including employee salaries, resource distribution, the performance of the PLC, and the southern issue.

He also spoke about the role of the UN envoy and what priorities Yemenis should undertake.

- Terrorist Attacks

Without ambiguity, Oppenheim described recent Houthi aggressions as terrorist attacks. He asserted that his country’s stance was firm on the Houthis’ latest three attacks on oil infrastructure in Yemen. These assaults, according to the ambassador, are terrorist in nature.

Regarding the government’s response to these attacks by blacklisting Houthi militias as a terrorist group, Oppenheim reminds all parties that the space for dialogue needs protection.

The ambassador warned that the Houthi terrorist designation by the government may have ramifications on humanitarian access.

Nevertheless, Oppenheim recalls how the Royal Navy’s HMS Montrose seized Iranian weapon-laden vessels that were en route to deliver to Houthis in Yemen.

Participating in Yemen’s Governance

Oppenheim did not hide his hopes for Houthis to come around and participate in Yemen’s PLC. He reiterated the UK’s support for PLC Chairman Rashad al-Alimi and the council’s remaining members.

According to the ambassador, the PLC brings together all of Yemen’s parties, except the Houthis.

Oppenheim noted that the PLC’s strength, unity, and stability, is vital for the current phase Yemen is experiencing.

He moved on to stress that Houthis, who continue to refuse sharing power in Yemen, do not enjoy international relations. The diplomat explained that what Houthis have are ties with some international representatives.

Oppenheim asserted that the Houthi government remains unrecognized.

In his opinion, Oppenheim believes that the real question in Yemen today is: How can parties share power and resources found in the country?

For this reason, Oppenheim notes that the question of salaries of public workers remains crucial and can be a prelude for a solution to the issue at hand.

He, however, acknowledged that the matter is up to Yemenis to decide how they want to manage the situation. Oppenheim also said that Yemenis must decide on what political structures might work in a future political settlement.

- PLC

PLC members have proven that they can work together, even when they do not agree on everything, affirmed Oppenheim.

As for whether disputes arise among PLC members, the British ambassador affirmed that they do, but continued to emphasize that coalition governments everywhere suffer from differences.

In fact, even within political parties there is often conflict in any country on various issues, but they still work together, the ambassador added.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.